ITU Unit Action

LIQUIDIA

Liquidia Technologies, Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 90218085 FILING DATE 09/28/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY HENRY, NAKIA D
L.O. ASSIGNED O20-NOT FOUND

PUB INFORMATION

RUN DATE 01/26/2022
PUB DATE 08/03/2021
STATUS 730-FIRST EXTENSION - GRANTED
STATUS DATE 01/24/2022
LITERAL MARK ELEMENT LIQUIDIA

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT LIQUIDIA
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Liquidia Technologies, Inc.
ADDRESS 419 Davis Drive, Suite 100
Morrisville, NC 27560
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 001
          DESCRIPTION TEXT Micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics used for the manufacture of medical and pharmaceutical goods and for general scientific and research purposes
INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics used for medical diagnostic and treatment purposes; Micro- and nano-particles with prophylactic properties, namely, those composed of polymers, excipients, therapeutics, and biologics used for medical diagnostic and treatment purposes
INTERNATIONAL CLASS 040
          DESCRIPTION TEXT Custom manufacture of micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics, for general scientific and research purposes; Custom manufacture of micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics used for the manufacture of medical and pharmaceutical goods and for general scientific and research purposes; custom manufacture of micro- and nano-particles, namely, those composed of polymers, excipients, therapeutics, and biologics used for medical diagnostic and treatment purposes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 001 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 040 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
DESCRIPTION OF MARK The mark consists of a circular design with hexagon figure on top of the circle and three lines drawn through both the circle design and hexagon, two lines angled across from each other on the top, and one vertical line at the bottom in the middle; the design is situated next to the wording "LIQUIDIA".
OWNER OF US REG NOS 3321419    5443598   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
01/26/2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 028
01/24/2022 EX1G S EXTENSION 1 GRANTED 027
01/24/2022 EXT1 S EXTENSION 1 FILED 026
01/24/2022 EEXT I TEAS EXTENSION RECEIVED 025
09/28/2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 024
08/03/2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 023
08/03/2021 PUBO A PUBLISHED FOR OPPOSITION 022
07/14/2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 021
06/25/2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 020
06/25/2021 XAEC I EXAMINER'S AMENDMENT ENTERED 019
06/24/2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED 018
06/24/2021 GNEA O EXAMINERS AMENDMENT E-MAILED 017
06/24/2021 CNEA R EXAMINERS AMENDMENT -WRITTEN 016
06/22/2021 XAEC I EXAMINER'S AMENDMENT ENTERED 015
06/22/2021 ALIE A ASSIGNED TO LIE 014
06/22/2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED 013
06/22/2021 GNEA O EXAMINERS AMENDMENT E-MAILED 012
06/22/2021 CNEA R EXAMINERS AMENDMENT -WRITTEN 011
06/17/2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 010
06/16/2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 009
06/16/2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 008
12/17/2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 007
12/17/2020 GNRT F NON-FINAL ACTION E-MAILED 006
12/17/2020 CNRT R NON-FINAL ACTION WRITTEN 005
12/16/2020 DOCK D ASSIGNED TO EXAMINER 004
11/10/2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED 003
11/09/2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
10/01/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Devon E. White
CORRESPONDENCE ADDRESS Devon E. White
WYRICK ROBBINS YATES & PONTON LLP
4101 LAKE BOONE TRAIL, SUITE 300
RALEIGH NC 27607
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Liquidia Technologies, Inc.
ADDRESS 419 Davis Drive, Suite 100
Morrisville, NC 27560
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed